Acyclovir

Product NDC: 63304-505
11-digit product format: 633040505
Labeler code: 63304
Product ID: 63304-505_7a18c7e7-b635-439a-8f8b-8dac5704fba6
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: acyclovir
Dosage form: TABLET
Route: ORAL
Labeler: Ranbaxy Laboratories Ltd.
Application: ANDA074980
Marketing category: ANDA
Marketing start: 1999-02-08
Marketing end: 0000-00-00
Substance: ACYCLOVIR
Active strength: 800 mg/1
Pharmacologic classes: DNA Polymerase Inhibitors [MoA],Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC],Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC],Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC],Nucleoside Analog [EXT]
NDC exclude flag: E
Listing certified through: 2018-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 4 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Source date
excluded product	product	63304-505		I	Inactivated by FDA	2026-08-10
excluded package	package	63304-505	63304-505-01	I	Inactivated by FDA	2026-08-10
excluded package	package	63304-505	63304-505-28	I	Inactivated by FDA	2026-08-10
excluded package	package	63304-505	63304-505-50	I	Inactivated by FDA	2026-08-10

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 2 · 88 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	63304-505-28	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	63304-505-50	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	63304-505-01	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	63304-505-28	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	63304-505-50	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	63304-505-01	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	63304-505-28	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	63304-505-50	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	63304-505-01	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	63304-505-28	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	63304-505-50	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	63304-505-01	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	63304-505-28	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	63304-505-50	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	63304-505-01	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	63304-505-28	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	63304-505-50	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	63304-505-01	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	63304-505-28	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	63304-505-50	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	63304-505-01	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	63304-505-28	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	63304-505-50	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	63304-505-01	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	63304-505-28	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	63304-505-50	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	63304-505-01	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	63304-505-28	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	63304-505-50	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	63304-505-01	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	63304-505-28	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	63304-505-50	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	63304-505-01	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	63304-505-28	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	63304-505-50	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	63304-505-01	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded product	product		`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded package	package	63304-505-28	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded package	package	63304-505-50	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded package	package	63304-505-01	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded product	product		`834df4deac94…`	`adcc014656a3…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded package	package	63304-505-28	`834df4deac94…`	`adcc014656a3…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded package	package	63304-505-50	`834df4deac94…`	`adcc014656a3…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded package	package	63304-505-01	`834df4deac94…`	`adcc014656a3…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded product	product		`1332a3947898…`	`d4bfe170f9cd…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded package	package	63304-505-28	`1332a3947898…`	`d4bfe170f9cd…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded package	package	63304-505-50	`1332a3947898…`	`d4bfe170f9cd…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded package	package	63304-505-01	`1332a3947898…`	`d4bfe170f9cd…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A074980-001	ACYCLOVIR	ACYCLOVIR	400MG	TABLET / ORAL			1998-09-30
A074980-002	ACYCLOVIR	ACYCLOVIR	800MG	TABLET / ORAL			1998-09-30

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 3 · 82 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Approval date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A074980-001	ACYCLOVIR	400MG	TABLET / ORAL	1998-09-30	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A074980-002	ACYCLOVIR	800MG	TABLET / ORAL	1998-09-30	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A074980-001	ACYCLOVIR	400MG	TABLET / ORAL	1998-09-30	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A074980-002	ACYCLOVIR	800MG	TABLET / ORAL	1998-09-30	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A074980-001	ACYCLOVIR	400MG	TABLET / ORAL	1998-09-30	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A074980-002	ACYCLOVIR	800MG	TABLET / ORAL	1998-09-30	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A074980-001	ACYCLOVIR	400MG	TABLET / ORAL	1998-09-30	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A074980-002	ACYCLOVIR	800MG	TABLET / ORAL	1998-09-30	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A074980-001	ACYCLOVIR	400MG	TABLET / ORAL	1998-09-30	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A074980-002	ACYCLOVIR	800MG	TABLET / ORAL	1998-09-30	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A074980-001	ACYCLOVIR	400MG	TABLET / ORAL	1998-09-30	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A074980-002	ACYCLOVIR	800MG	TABLET / ORAL	1998-09-30	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A074980-001	ACYCLOVIR	400MG	TABLET / ORAL	1998-09-30	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A074980-002	ACYCLOVIR	800MG	TABLET / ORAL	1998-09-30	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A074980-001	ACYCLOVIR	400MG	TABLET / ORAL	1998-09-30	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A074980-002	ACYCLOVIR	800MG	TABLET / ORAL	1998-09-30	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A074980-001	ACYCLOVIR	400MG	TABLET / ORAL	1998-09-30	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A074980-002	ACYCLOVIR	800MG	TABLET / ORAL	1998-09-30	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A074980-001	ACYCLOVIR	400MG	TABLET / ORAL	1998-09-30	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A074980-002	ACYCLOVIR	800MG	TABLET / ORAL	1998-09-30	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A074980-001	ACYCLOVIR	400MG	TABLET / ORAL	1998-09-30	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A074980-002	ACYCLOVIR	800MG	TABLET / ORAL	1998-09-30	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A074980-001	ACYCLOVIR	400MG	TABLET / ORAL	1998-09-30	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A074980-002	ACYCLOVIR	800MG	TABLET / ORAL	1998-09-30	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A074980-001	ACYCLOVIR	400MG	TABLET / ORAL	1998-09-30	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A074980-002	ACYCLOVIR	800MG	TABLET / ORAL	1998-09-30	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A074980-001	ACYCLOVIR	400MG	TABLET / ORAL	1998-09-30	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	A074980-002	ACYCLOVIR	800MG	TABLET / ORAL	1998-09-30	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A074980-001	ACYCLOVIR	400MG	TABLET / ORAL	1998-09-30	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A074980-002	ACYCLOVIR	800MG	TABLET / ORAL	1998-09-30	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A074980-001	ACYCLOVIR	400MG	TABLET / ORAL	1998-09-30	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	A074980-002	ACYCLOVIR	800MG	TABLET / ORAL	1998-09-30	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A074980-001	ACYCLOVIR	400MG	TABLET / ORAL	1998-09-30	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	A074980-002	ACYCLOVIR	800MG	TABLET / ORAL	1998-09-30	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A074980-001	ACYCLOVIR	400MG	TABLET / ORAL	1998-09-30	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A074980-002	ACYCLOVIR	800MG	TABLET / ORAL	1998-09-30	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A074980-001	ACYCLOVIR	400MG	TABLET / ORAL	1998-09-30	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	A074980-002	ACYCLOVIR	800MG	TABLET / ORAL	1998-09-30	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A074980-001	ACYCLOVIR	400MG	TABLET / ORAL	1998-09-30	`782e0a99824c…`
2021-12-28 21:50 UTC	2021-12	A074980-002	ACYCLOVIR	800MG	TABLET / ORAL	1998-09-30	`782e0a99824c…`

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
33190c02-82e1-0a4d-d716-9ccd23588463	Product name	5	20250225
c367d1da-5a72-8966-6d11-1eb9a73ae758	Product name	3	20231115
5518bf13-db2f-2e9c-3679-e70ecf03752c	Product name	9	20210614
27897900-0e40-497b-97e1-88057e68fe6c	Product name	4	20200710
ca834e59-e669-229c-9288-0ccb76dc373e	Product name	9	20200220
d7f95c49-d3e1-4bbc-a389-e9cd73f59a28	Product name	1	20190702
fb15b394-3715-4c87-a447-421489aa8739	Product name	3	20170727
7bdc4804-3832-c0df-e519-72b6d47c9792	Product name	1	20140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
63304-505-01	2020-01-31	C162847	48780-1	9d75b9d0-afde-f424-e053-dadaa90a57ce	ACYCLOVIR CAPSULES, USP AND ACYCLOVIR TABLETS, USP Rx only
63304-505-28	2020-01-31	C162847	48780-1	9d75b9d0-afde-f424-e053-dadaa90a57ce	ACYCLOVIR CAPSULES, USP AND ACYCLOVIR TABLETS, USP Rx only
63304-505-50	2020-01-31	C162847	48780-1	9d75b9d0-afde-f424-e053-dadaa90a57ce	ACYCLOVIR CAPSULES, USP AND ACYCLOVIR TABLETS, USP Rx only

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
63304-505-01	Acyclovir	100 in 1 BOTTLE	TABLET	100	5
63304-505-28	Acyclovir	180 in 1 BOTTLE	TABLET	180	5
63304-505-50	Acyclovir	50 in 1 BOTTLE	TABLET	50	5

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
63304-505-01	EA - Each	63304-505	9d731f11-58b5-4dd7-96e7-341fe2e3c6b4	1	2012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
ACYCLOVIR	ACTIVE INGREDIENT	X4HES1O11F	ACYCLOVIR CAPSULE ACYCLOVIR TABLET [RANBAXY LABORATORIES LTD.]	5
ACYCLOVIR	ACTIVE MOIETY	X4HES1O11F	ACYCLOVIR CAPSULE ACYCLOVIR TABLET [RANBAXY LABORATORIES LTD.]	5
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	ACYCLOVIR CAPSULE ACYCLOVIR TABLET [RANBAXY LABORATORIES LTD.]	5
FERROSOFERRIC OXIDE	INACTIVE INGREDIENT	XM0M87F357	ACYCLOVIR CAPSULE ACYCLOVIR TABLET [RANBAXY LABORATORIES LTD.]	5
GELATIN	INACTIVE INGREDIENT	2G86QN327L	ACYCLOVIR CAPSULE ACYCLOVIR TABLET [RANBAXY LABORATORIES LTD.]	5
LACTOSE MONOHYDRATE	INACTIVE INGREDIENT	EWQ57Q8I5X	ACYCLOVIR CAPSULE ACYCLOVIR TABLET [RANBAXY LABORATORIES LTD.]	5
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	ACYCLOVIR CAPSULE ACYCLOVIR TABLET [RANBAXY LABORATORIES LTD.]	5
PROPYLENE GLYCOL	INACTIVE INGREDIENT	6DC9Q167V3	ACYCLOVIR CAPSULE ACYCLOVIR TABLET [RANBAXY LABORATORIES LTD.]	5
SILICON DIOXIDE	INACTIVE INGREDIENT	ETJ7Z6XBU4	ACYCLOVIR CAPSULE ACYCLOVIR TABLET [RANBAXY LABORATORIES LTD.]	5
SODIUM STARCH GLYCOLATE TYPE A CORN	INACTIVE INGREDIENT	AG9B65PV6B	ACYCLOVIR CAPSULE ACYCLOVIR TABLET [RANBAXY LABORATORIES LTD.]	5
STARCH, CORN	INACTIVE INGREDIENT	O8232NY3SJ	ACYCLOVIR CAPSULE ACYCLOVIR TABLET [RANBAXY LABORATORIES LTD.]	5
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	ACYCLOVIR CAPSULE ACYCLOVIR TABLET [RANBAXY LABORATORIES LTD.]	5
ACYCLOVIR	ACTIVE INGREDIENT	X4HES1O11F	ACYCLOVIR TABLET [STAT RX USA]	2
ACYCLOVIR	ACTIVE MOIETY	X4HES1O11F	ACYCLOVIR TABLET [STAT RX USA]	2
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	ACYCLOVIR TABLET [STAT RX USA]	2
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	ACYCLOVIR TABLET [STAT RX USA]	2
SILICON DIOXIDE	INACTIVE INGREDIENT	ETJ7Z6XBU4	ACYCLOVIR TABLET [STAT RX USA]	2
Acyclovir	ACTIVE INGREDIENT	X4HES1O11F	ACYCLOVIR CAPSULE ACYCLOVIR TABLET [REBEL DISTRIBUTORS CORP]	1
acyclovir	ACTIVE MOIETY	X4HES1O11F	ACYCLOVIR CAPSULE ACYCLOVIR TABLET [REBEL DISTRIBUTORS CORP]	1
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	ACYCLOVIR CAPSULE ACYCLOVIR TABLET [REBEL DISTRIBUTORS CORP]	1
colloidal silicon dioxide	INACTIVE INGREDIENT	ETJ7Z6XBU4	ACYCLOVIR CAPSULE ACYCLOVIR TABLET [REBEL DISTRIBUTORS CORP]	1
FERROSOFERRIC OXIDE	INACTIVE INGREDIENT	XM0M87F357	ACYCLOVIR CAPSULE ACYCLOVIR TABLET [REBEL DISTRIBUTORS CORP]	1
gelatin	INACTIVE INGREDIENT	2G86QN327L	ACYCLOVIR CAPSULE ACYCLOVIR TABLET [REBEL DISTRIBUTORS CORP]	1
lactose monohydrate	INACTIVE INGREDIENT	EWQ57Q8I5X	ACYCLOVIR CAPSULE ACYCLOVIR TABLET [REBEL DISTRIBUTORS CORP]	1
magnesium stearate	INACTIVE INGREDIENT	70097M6I30	ACYCLOVIR CAPSULE ACYCLOVIR TABLET [REBEL DISTRIBUTORS CORP]	1
SODIUM STARCH GLYCOLATE TYPE A POTATO	INACTIVE INGREDIENT	5856J3G2A2	ACYCLOVIR CAPSULE ACYCLOVIR TABLET [REBEL DISTRIBUTORS CORP]	1
STARCH, CORN	INACTIVE INGREDIENT	O8232NY3SJ	ACYCLOVIR CAPSULE ACYCLOVIR TABLET [REBEL DISTRIBUTORS CORP]	1
titanium dioxide	INACTIVE INGREDIENT	15FIX9V2JP	ACYCLOVIR CAPSULE ACYCLOVIR TABLET [REBEL DISTRIBUTORS CORP]	1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
63304-505	ACYCLOVIR CAPSULE ACYCLOVIR TABLET [RANBAXY LABORATORIES LTD.]	5	Legacy NDC, 3 package rows	20130930_d13b8cdd-59fd-472b-8125-a19f42ef5402.zip

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
X4HES1O11F	ACYCLOVIR	59277-89-3	ACYCLOVIR

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
197310	acyclovir 200 MG Oral Capsule	PSN	d13b8cdd-59fd-472b-8125-a19f42ef5402	5
197311	acyclovir 400 MG Oral Tablet	PSN	d13b8cdd-59fd-472b-8125-a19f42ef5402	5
197313	acyclovir 800 MG Oral Tablet	PSN	d13b8cdd-59fd-472b-8125-a19f42ef5402	5
197310	acyclovir 200 MG Oral Capsule	SCD	d13b8cdd-59fd-472b-8125-a19f42ef5402	5
197311	acyclovir 400 MG Oral Tablet	SCD	d13b8cdd-59fd-472b-8125-a19f42ef5402	5
197313	acyclovir 800 MG Oral Tablet	SCD	d13b8cdd-59fd-472b-8125-a19f42ef5402	5
197310	acycycloguanosine 200 MG Oral Capsule	SY	d13b8cdd-59fd-472b-8125-a19f42ef5402	5
197311	acycycloguanosine 400 MG Oral Tablet	SY	d13b8cdd-59fd-472b-8125-a19f42ef5402	5
197313	acycycloguanosine 800 MG Oral Tablet	SY	d13b8cdd-59fd-472b-8125-a19f42ef5402	5
197311	acyclovir 400 MG Oral Tablet	PSN	3b80d222-4d88-4ddd-afbf-8f316e9463d5	2
197313	acyclovir 800 MG Oral Tablet	PSN	3b80d222-4d88-4ddd-afbf-8f316e9463d5	2
197311	acyclovir 400 MG Oral Tablet	SCD	3b80d222-4d88-4ddd-afbf-8f316e9463d5	2
197313	acyclovir 800 MG Oral Tablet	SCD	3b80d222-4d88-4ddd-afbf-8f316e9463d5	2
197311	acycycloguanosine 400 MG Oral Tablet	SY	3b80d222-4d88-4ddd-afbf-8f316e9463d5	2
197313	acycycloguanosine 800 MG Oral Tablet	SY	3b80d222-4d88-4ddd-afbf-8f316e9463d5	2
197310	acyclovir 200 MG Oral Capsule	PSN	a2db7131-bf31-47bf-bf61-594f919af1f2	1
197311	acyclovir 400 MG Oral Tablet	PSN	a2db7131-bf31-47bf-bf61-594f919af1f2	1
197313	acyclovir 800 MG Oral Tablet	PSN	a2db7131-bf31-47bf-bf61-594f919af1f2	1
197310	acyclovir 200 MG Oral Capsule	SCD	a2db7131-bf31-47bf-bf61-594f919af1f2	1
197311	acyclovir 400 MG Oral Tablet	SCD	a2db7131-bf31-47bf-bf61-594f919af1f2	1
197313	acyclovir 800 MG Oral Tablet	SCD	a2db7131-bf31-47bf-bf61-594f919af1f2	1
197310	acycycloguanosine 200 MG Oral Capsule	SY	a2db7131-bf31-47bf-bf61-594f919af1f2	1
197311	acycycloguanosine 400 MG Oral Tablet	SY	a2db7131-bf31-47bf-bf61-594f919af1f2	1
197313	acycycloguanosine 800 MG Oral Tablet	SY	a2db7131-bf31-47bf-bf61-594f919af1f2	1

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Status
63304-505-01	63304050501	100 in 1 BOTTLE	Historical
63304-505-28	63304050528	180 in 1 BOTTLE	Historical
63304-505-50	63304050550	50 in 1 BOTTLE	Historical

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
ACYCLOVIR CAPSULES, USP AND ACYCLOVIR TABLETS, USP Rx only	Ranbaxy Laboratories Ltd. \| Ohm Laboratories Inc_Livingston	2013-09-06	HUMAN PRESCRIPTION DRUG LABEL	5
ACYCLOVIR - Stat Rx USA	Stat Rx USA	2011-02-10	HUMAN PRESCRIPTION DRUG LABEL	2
Acyclovir	Rebel Distributors Corp	2011-01-05	HUMAN PRESCRIPTION DRUG LABEL	1